Donate
Member Login
Mobile Buttons
Donate
Member Login
About Us
About ANZCHOG
Board of Directors
Our People
Membership
Supporters & Partners
Why childhood cancer is different
Collaborations
Equitable Pathways
Resources
Clinical Trials & Research
Clinical Trials
Research
ANZCHOG Children’s Cancer Clinical Trials Repository
CIRCAA
Annual Scientific Meeting
News & Events
News
Events
Position Statements & Guidelines
Contact Us
Last Updated | 30 March 2026
ACNS1821
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed paediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
External Registry
Site Status
Queensland Children's Hospital Sydney Children's Hospital Royal Children's Hospital Perth Children's Hospital Children's Hospital at Westmead Starship Children's Hospital Christchurch Hospital
Queensland Children's Hospital
(QLD)
John Hunter Children's Hospital
(NSW)
Sydney Children's Hospital
(NSW)
Monash Health Clayton
(VIC)
Royal Children's Hospital
(VIC)
Women's and Children's Hospital
(SA)
Perth Children's Hospital
(WA)
Royal Hobart Hospital
(TAS)
Children's Hospital at Westmead
(NSW)
Starship Children's Hospital
(NZ)
Christchurch Hospital
(NZ)
Preparing to Open
Open
Temporarily Closed
Closed
Complete
Adult Sites
These sites are not monitored. Status may vary.
Diagnosis Stage
Newly Diagnosed
National Sponsor
National Cancer Institute (NCI)
Open Date
05/05/2022
Conditions
Anaplastic Astrocytoma
Anaplastic Astrocytoma, Not Otherwise Specified
Diffuse Intrinsic Pontine Glioma
Diffuse Midline Glioma, H3 K27M-Mutant
Glioblastoma
Glioblastoma, Not Otherwise Specified
Malignant Glioma
Patient Range
12 months
–
21 years
0
50
99+
Disease Type
Brain and Spinal (Central Nervous System) Tumours
Study Type
Interventional
International Sponsor
N/A
Join our newsletter
"
*
" indicates required fields
Company
This field is for validation purposes and should be left unchanged.
Full Name
*
Email
*